In vitro antimicrobial effects of a novel Pentaherbs concoction for atopic dermatitis

Area of Science:

• Dermatology
• Microbiology
• Herbal Medicine

Background:

• Atopic eczema (AE) is a condition where the skin's natural defenses may be compromised.
• Previous research has established the immunologic effects and clinical efficacy of PentaHerbs Formula (PHF) in treating pediatric atopic eczema.
• This study focuses on the potential antimicrobial properties of PHF.

Purpose of the Study:

• To investigate the antimicrobial effects of PentaHerbs Formula (PHF).
• To determine the impact of PHF on the minimal inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of common skin bacteria found in atopic eczema patients.

Main Methods:

• The study evaluated the MIC and MBC of PHF against a panel of bacteria.
• Bacteria tested included Staphylococcus aureus, Methicillin-resistant Staphylococcus aureus (MRSA), Enterococcus faecalis, Pseudomonas aeruginosa, Escherichia coli, Enterobacter cloacae, Proteus vulgaris, and Acinetobacter baumannii.

Main Results:

• PentaHerbs Formula (PHF) exhibited notable effectiveness against Staphylococcus aureus (ATCC 25923) and Methicillin-resistant Staphylococcus aureus (MRSA) (ATCC BAA-43).
• The minimal inhibitory concentration (MIC) for these strains was 1 mg/mL, and the minimum bactericidal concentration (MBC) was 25 mg/mL.

Conclusions:

• PentaHerbs Formula (PHF) demonstrates significant antimicrobial activity, especially against Staphylococcus aureus and MRSA.
• PHF holds promise for development as a topical treatment targeting Staphylococcus aureus infections.